In last trading session, Adicet Bio Inc (NASDAQ:ACET) saw 0.3 million shares changing hands with its beta currently measuring 1.99. Company’s recent per share price level of $0.97 trading at -$0.03 or -2.66% at ring of the bell on the day assigns it a market valuation of $80.21M. That closing price of ACET’s stock is at a discount of -196.91% from its 52-week high price of $2.88 and is indicating a premium of 16.49% from its 52-week low price of $0.81.
For Adicet Bio Inc (ACET), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.35 in the current quarter.
Adicet Bio Inc (NASDAQ:ACET) trade information
Upright in the red during last session for losing -2.66%, in the last five days ACET remained trading in the green while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $0.97 price level, adding 6.73% to its value on the day. Adicet Bio Inc’s shares saw a change of 1.19% in year-to-date performance and have moved 8.22% in past 5-day. Adicet Bio Inc (NASDAQ:ACET) showed a performance of 6.03% in past 30-days.
Wall Street analysts have assigned a consensus price target of 32.5 to the stock, which implies a rise of 97.02% to its current value. Analysts have been projecting 27 as a low price target for the stock while placing it at a high target of 38. It follows that stock’s current price would drop -2683.51% in reaching the projected high whereas dropping to the targeted low would mean a loss of -2683.51% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 19.75% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 51.96% while estimates for its earnings growth in next 5 years are of 22.99%.
Adicet Bio Inc (NASDAQ:ACET)’s Major holders
ORBIMED ADVISORS LLC is the top institutional holder at ACET for having 11.45 million shares of worth $13.85 million. And as of 2024-06-30, it was holding 12.6303 of the company’s outstanding shares.
The second largest institutional holder is TANG CAPITAL MANAGEMENT LLC, which was holding about 8.22 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.0663 of outstanding shares, having a total worth of $9.94 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 2.07 shares of worth $2.02 million or 2.51% of the total outstanding shares. The later fund manager was in possession of 1.08 shares on Sep 30, 2024 , making its stake of worth around $1.05 million in the company or a holder of 1.31% of company’s stock.
